annual D&A:
$1.06M+$378.80K(+55.74%)Summary
- As of today (August 31, 2025), VRNA annual depreciation & amortization is $1.06 million, with the most recent change of +$378.80 thousand (+55.74%) on December 31, 2024.
- During the last 3 years, VRNA annual D&A has risen by +$429.50 thousand (+68.29%).
- VRNA annual D&A is now at all-time high.
Performance
VRNA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$296.90K+$800.00(+0.27%)Summary
- As of today (August 31, 2025), VRNA quarterly depreciation & amortization is $296.90 thousand, with the most recent change of +$800.00 (+0.27%) on June 1, 2025.
- Over the past year, VRNA quarterly D&A has increased by +$26.60 thousand (+9.84%).
- VRNA quarterly D&A is now at all-time high.
Performance
VRNA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.12M+$26.60K(+2.44%)Summary
- As of today (August 31, 2025), VRNA TTM depreciation & amortization is $1.12 million, with the most recent change of +$26.60 thousand (+2.44%) on June 1, 2025.
- Over the past year, VRNA TTM D&A has increased by +$221.50 thousand (+24.70%).
- VRNA TTM D&A is now at all-time high.
Performance
VRNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VRNA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.7% | +9.8% | +24.7% |
| 3 y3 years | +68.3% | +81.2% | +72.1% |
| 5 y5 years | +106.7% | +91.1% | +63.9% |
VRNA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.3% | at high | +92.8% | at high | +78.8% |
| 5 y | 5-year | at high | +106.7% | at high | +95.7% | at high | +141.2% |
| alltime | all time | at high | >+9999.0% | at high | +1384.5% | at high | +5491.5% |
VRNA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $296.90K(+0.3%) | $1.12M(+2.4%) |
| Mar 2025 | - | $296.10K(+15.7%) | $1.09M(+3.1%) |
| Dec 2024 | $1.06M(+55.7%) | $255.90K(-5.0%) | $1.06M(+4.7%) |
| Sep 2024 | - | $269.40K(-0.3%) | $1.01M(+12.7%) |
| Jun 2024 | - | $270.30K(+2.9%) | $896.80K(+14.4%) |
| Mar 2024 | - | $262.80K(+26.0%) | $784.10K(+15.4%) |
| Dec 2023 | $679.60K(+6.9%) | $208.60K(+34.5%) | $679.70K(+8.5%) |
| Sep 2023 | - | $155.10K(-1.6%) | $626.70K(+0.2%) |
| Jun 2023 | - | $157.60K(-0.5%) | $625.60K(-1.0%) |
| Mar 2023 | - | $158.40K(+1.8%) | $631.90K(-0.6%) |
| Dec 2022 | $635.60K(+1.1%) | $155.60K(+1.0%) | $635.60K(-0.8%) |
| Sep 2022 | - | $154.00K(-6.0%) | $640.80K(-1.4%) |
| Jun 2022 | - | $163.90K(+1.1%) | $649.70K(+1.9%) |
| Mar 2022 | - | $162.10K(+0.8%) | $637.50K(+1.4%) |
| Dec 2021 | $628.90K(+0.2%) | $160.80K(-1.3%) | $628.90K(+34.4%) |
| Sep 2021 | - | $162.90K(+7.4%) | $468.10K(+1.0%) |
| Jun 2021 | - | $151.70K(-1.2%) | $463.60K(-0.8%) |
| Mar 2021 | - | $153.50K(-3.1%) | $467.30K(-29.3%) |
| Dec 2020 | $627.80K(+22.6%) | - | - |
| Sep 2020 | - | $158.40K(+1.9%) | $661.10K(-3.1%) |
| Jun 2020 | - | $155.40K(-2.9%) | $682.50K(+2.8%) |
| Mar 2020 | - | $160.10K(-14.5%) | $664.20K(+4.3%) |
| Dec 2019 | $512.10K | $187.20K(+4.1%) | $636.90K(+31.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $179.80K(+31.1%) | $484.20K(+44.1%) |
| Jun 2019 | - | $137.10K(+3.2%) | $336.10K(+44.7%) |
| Mar 2019 | - | $132.80K(+284.9%) | $232.30K(+76.7%) |
| Dec 2018 | $130.70K(-17.5%) | $34.50K(+8.8%) | $131.50K(-28.8%) |
| Sep 2018 | - | $31.70K(-4.8%) | $184.80K(+3.2%) |
| Jun 2018 | - | $33.30K(+4.1%) | $179.10K(+4.5%) |
| Mar 2018 | - | $32.00K(-63.6%) | $171.40K(+7.5%) |
| Dec 2017 | $158.40K(+89.2%) | $87.80K(+237.7%) | $159.40K(+122.6%) |
| Sep 2017 | - | $26.00K(+1.6%) | $71.60K(+57.0%) |
| Jun 2017 | - | $25.60K(+28.0%) | $45.60K(+128.0%) |
| Mar 2017 | - | $20.00K | $20.00K |
| Dec 2016 | $83.70K(+3.3%) | - | - |
| Dec 2015 | $81.00K(-7.1%) | - | - |
| Dec 2014 | $87.20K(+48.0%) | - | - |
| Dec 2013 | $58.90K(+21.7%) | - | - |
| Dec 2012 | $48.40K(+28.4%) | - | - |
| Dec 2011 | $37.70K(+14.6%) | - | - |
| Dec 2010 | $32.90K(-5.5%) | - | - |
| Dec 2009 | $34.80K(+1.5%) | - | - |
| Dec 2008 | $34.30K(+26.1%) | - | - |
| Dec 2007 | $27.20K(+532.6%) | - | - |
| Dec 2006 | $4300.00(>+9900.0%) | - | - |
| Dec 2005 | $0.00 | - | - |
FAQ
- What is Verona Pharma plc annual depreciation & amortization?
- What is the all time high annual D&A for Verona Pharma plc?
- What is Verona Pharma plc annual D&A year-on-year change?
- What is Verona Pharma plc quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Verona Pharma plc?
- What is Verona Pharma plc quarterly D&A year-on-year change?
- What is Verona Pharma plc TTM depreciation & amortization?
- What is the all time high TTM D&A for Verona Pharma plc?
- What is Verona Pharma plc TTM D&A year-on-year change?
What is Verona Pharma plc annual depreciation & amortization?
The current annual D&A of VRNA is $1.06M
What is the all time high annual D&A for Verona Pharma plc?
Verona Pharma plc all-time high annual depreciation & amortization is $1.06M
What is Verona Pharma plc annual D&A year-on-year change?
Over the past year, VRNA annual depreciation & amortization has changed by +$378.80K (+55.74%)
What is Verona Pharma plc quarterly depreciation & amortization?
The current quarterly D&A of VRNA is $296.90K
What is the all time high quarterly D&A for Verona Pharma plc?
Verona Pharma plc all-time high quarterly depreciation & amortization is $296.90K
What is Verona Pharma plc quarterly D&A year-on-year change?
Over the past year, VRNA quarterly depreciation & amortization has changed by +$26.60K (+9.84%)
What is Verona Pharma plc TTM depreciation & amortization?
The current TTM D&A of VRNA is $1.12M
What is the all time high TTM D&A for Verona Pharma plc?
Verona Pharma plc all-time high TTM depreciation & amortization is $1.12M
What is Verona Pharma plc TTM D&A year-on-year change?
Over the past year, VRNA TTM depreciation & amortization has changed by +$221.50K (+24.70%)